Skip to main content
Back to companies
Hayward, California, United StatesFounded 199131+ employeesARDM
$75.5M raisedIPO· last: post ipo debt (May 2016)· 3 rounds
Backed by(4 investors)
Castle Creek PartnersDomain AssociatesCamden PartnersNew Enterprise Associates

Aradigm is a benefits platform for cell and gene therapies (CGT) designed to provide sustainable access to life-saving medicines. Our novel financial and delivery model addresses the challenges facing every stakeholder—payers, providers, manufacturers, and, most importantly, patients. By creating a large-scale risk pool to cover and pay for all CGT drugs and care, with unspent funds returned, we can deliver cost predictability for employers and health plans. Our end-to-end experience includes a national network of "centers of excellence” and concierge patient support, giving providers volume and rate certainty and patients appropriate, high-quality treatment and outcomes.

Founders

Skip jobs list

Open Positions at Aradigm (0 Jobs)

No open positions at the moment.
Try adjusting your filters or browse all jobs
Browse All Jobs